These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
511 related articles for article (PubMed ID: 22640570)
21. Schwann cells co-cultured with stimulated T cells and antigen express major histocompatibility complex (MHC) class II determinants without interferon-gamma pretreatment: synergistic effects of interferon-gamma and tumor necrosis factor on MHC class II induction. Kingston AE; Bergsteinsdottir K; Jessen KR; Van der Meide PH; Colston MJ; Mirsky R Eur J Immunol; 1989 Jan; 19(1):177-83. PubMed ID: 2493382 [TBL] [Abstract][Full Text] [Related]
22. Immunopharmacology of the superantigen staphylococcal enterotoxin A in T-cell receptor V beta 3 transgenic mice. Dohlsten M; Björklund M; Sundstedt A; Hedlund G; Samson D; Kalland T Immunology; 1993 Aug; 79(4):520-7. PubMed ID: 7691731 [TBL] [Abstract][Full Text] [Related]
23. Upregulation of IgE synthesis by staphylococcal toxic shock syndrome toxin-1 in peripheral blood mononuclear cells from patients with atopic dermatitis. Hofer MF; Lester MR; Schlievert PM; Leung DY Clin Exp Allergy; 1995 Dec; 25(12):1218-27. PubMed ID: 8821303 [TBL] [Abstract][Full Text] [Related]
24. Expression of costimulatory molecules on human retinoblastoma cells Y-79: functional expression of CD40 and B7H1. Usui Y; Okunuki Y; Hattori T; Takeuchi M; Kezuka T; Goto H; Usui M Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4607-13. PubMed ID: 17003458 [TBL] [Abstract][Full Text] [Related]
25. MHC class II-dependent abnormal reactivity toward bacterial superantigens in immune cells of NOD mice. Radons J; Burkart V; Kolb H Diabetes; 1997 Mar; 46(3):379-85. PubMed ID: 9032092 [TBL] [Abstract][Full Text] [Related]
26. Inverse relationship between toxic shock syndrome toxin-1 antibodies and interferon-γ and interleukin-6 in peripheral blood mononuclear cells from patients with pediatric tonsillitis caused by Staphylococcus aureus. Chen Y; Huang Y; Liang B; Dong H; Yao S; Xie Y; Long Y; Zhong H; Yang Y; Zhu B; Gong S; Zhou Z Int J Pediatr Otorhinolaryngol; 2017 Jun; 97():211-217. PubMed ID: 28483238 [TBL] [Abstract][Full Text] [Related]
27. A novel HLA class II-independent TCR-mediated T cell activation mechanism is distinguished by the V beta specificity of the proliferating oligoclones and their capacity to generate interleukin-2. Dennig D; Yan Y; Ferguson K; O'Reilly RJ Cell Immunol; 1996 Aug; 171(2):200-10. PubMed ID: 8806788 [TBL] [Abstract][Full Text] [Related]
28. Xenogeneic cells and superantigen induce human T-cell activation in the absence of T-cell recognition of xenoantigen. Diaz LA; Pai R; Endres J; Anthony P; Duzyj C; Bishu S; Morita Y; Fox DA J Lab Clin Med; 2003 Sep; 142(3):149-57. PubMed ID: 14532902 [TBL] [Abstract][Full Text] [Related]
29. T regulatory cells in atopic dermatitis and subversion of their activity by superantigens. Ou LS; Goleva E; Hall C; Leung DY J Allergy Clin Immunol; 2004 Apr; 113(4):756-63. PubMed ID: 15100684 [TBL] [Abstract][Full Text] [Related]
30. Intercellular adhesion molecule-1 and leukocyte function-associated antigen-3 provide costimulation for superantigen-induced T lymphocyte proliferation in the absence of a specific presenting molecule. Lamphear JG; Stevens KR; Rich RR J Immunol; 1998 Jan; 160(2):615-23. PubMed ID: 9551895 [TBL] [Abstract][Full Text] [Related]
31. Carboxy-terminal residues of major histocompatibility complex class II-associated peptides control the presentation of the bacterial superantigen toxic shock syndrome toxin-1 to T cells. Wen R; Broussard DR; Surman S; Hogg TL; Blackman MA; Woodland DL Eur J Immunol; 1997 Mar; 27(3):772-81. PubMed ID: 9079821 [TBL] [Abstract][Full Text] [Related]
32. Superantigen toxic shock syndrome toxin-1 (TSST-1) enhances the replication of HIV-1 in peripheral blood mononuclear cells through selective activation of CD4+ T lymphocytes. Hashimoto K; Shigeta S; Baba M J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(4):393-9. PubMed ID: 7583434 [TBL] [Abstract][Full Text] [Related]
33. Exogenous and endogenous antigens are differentially presented by mast cells to CD4+ T lymphocytes. Frandji P; Tkaczyk C; Oskeritzian C; David B; Desaymard C; Mécheri S Eur J Immunol; 1996 Oct; 26(10):2517-28. PubMed ID: 8898968 [TBL] [Abstract][Full Text] [Related]
34. Patterns of interferon-gamma mRNA expression in toxic shock syndrome toxin-1 expanded V beta 11+ T lymphocytes. Zhao YX; Abdelnour A; Ljungdahl A; Olsson T; Tarkowski A Cell Immunol; 1995 Mar; 161(1):28-33. PubMed ID: 7867082 [TBL] [Abstract][Full Text] [Related]
35. Regulation of superantigen-induced T cell activation in the absence and the presence of MHC class II. Lando PA; Olsson C; Kalland T; Newton D; Kotb M; Dohlsten M J Immunol; 1996 Oct; 157(7):2857-63. PubMed ID: 8816390 [TBL] [Abstract][Full Text] [Related]
36. Dissection of the function of HLA class II and costimulation in B cell-mediated and toxic shock syndrome toxin-1-induced T cell proliferation. Dennig D; O'Reilly RJ J Immunol; 1993 Jun; 150(12):5231-40. PubMed ID: 7685791 [TBL] [Abstract][Full Text] [Related]
37. Human peripheral gammadelta T cells potentiate the early proinflammatory cytokine response to staphylococcal toxic shock syndrome toxin-1. Kalyan S; Chow AW J Infect Dis; 2004 May; 189(10):1892-6. PubMed ID: 15122526 [TBL] [Abstract][Full Text] [Related]
38. Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo. Poncelet AJ; Vercruysse J; Saliez A; Gianello P Transplantation; 2007 Mar; 83(6):783-90. PubMed ID: 17414713 [TBL] [Abstract][Full Text] [Related]
39. MHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance? Walter W; Lingnau K; Schmitt E; Loos M; Maeurer MJ Br J Cancer; 2000 Nov; 83(9):1192-201. PubMed ID: 11027433 [TBL] [Abstract][Full Text] [Related]
40. T-cell response to superantigen restimulation during menstrual toxic shock syndrome. Rasigade JP; Thomas D; Perpoint T; Peyramond D; Chidiac C; Etienne J; Vandenesch F; Lina G; Ferry T FEMS Immunol Med Microbiol; 2011 Aug; 62(3):368-71. PubMed ID: 21492259 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]